Rainbow Children's Medicare Ltd
Un-audited financial results (Standalone & Consolidated) for the quarter ended June 30, 2026
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 30 Jul 2026, 04:31 PM IST · BSE ID: 6582c811-4fea-482c-ba46-1b801e4d8284
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial results, elevated a key executive, issued employee shares, and advanced two hospital expansion projects.
🤖 AI Summary
- Rainbow Children's Medicare Board approved Q1 FY27 unaudited standalone and consolidated financial results.
- Standalone Profit After Tax for the quarter ended June 30, 2026, was Rs. 527.06 Million.
- Mr. Anshuman Jaiswal was elevated to Chief Legal Officer and designated as Senior Management Personnel.
- The company allotted 7,483 equity shares under the Employee Stock Unit Plan 2023.
- Agreements were executed for a new children and women's hospital in Malad, Mumbai and 64% partnership interest acquisition of Super Prime Medical Care LLP for Rs. 198 Million.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations (Q1 FY27)
4,105.47 Million
Standalone Profit after tax (Q1 FY27)
527.06 Million
Standalone Basic EPS (Q1 FY27)
5.20 Rs
Acquisition of Super Prime Medical Care LLP (Partnership Interest)
64%
Acquisition of Super Prime Medical Care LLP (Consideration)
198 Million
🏢 How This Affects the Company
The proposed capacity addition through a new hospital in Malad, Mumbai, and the acquisition of 64% partnership interest in Super Prime Medical Care LLP at Nellore, Andhra Pradesh, indicates expansion in medical and healthcare services.
The acquisition of 64% partnership interest in Super Prime Medical Care LLP for Rs. 198 Million represents a direct capital deployment for inorganic growth. Q1 FY27 standalone revenue from operations was Rs. 4,105.47 Million.
The elevation of Mr. Anshuman Jaiswal to Chief Legal Officer strengthens the company's legal leadership at the senior management level. The new hospital and acquisition will expand the company's operational footprint.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders who held shares as of July 29, 2026, received the final dividend of Rs. 3.50 per Equity Share for FY26. Employees granted stock options under ESOP 2025 or who exercised options under Stock Unit Plan 2023 are directly affected.
🔍
Management Signal
The elevation of Mr. Anshuman Jaiswal to Chief Legal Officer and ongoing expansion initiatives indicate management's focus on strengthening leadership and pursuing strategic growth.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor revenue and profit trends.
Completion of Malad, Mumbai hospital development in Q2 FY27.
Completion of Super Prime Medical Care LLP acquisition in Q2 FY27.
LOW RISK
The filing indicates growth initiatives and routine quarterly results, with no new significant risks.
💡 Investor Takeaway
Rainbow Children's Medicare reported Q1 FY27 standalone Profit After Tax of Rs. 527.06 Million, an increase from Rs. 517.20 Million in Q1 FY26. Revenue from operations for the quarter stood at Rs. 4,105.47 Million, up from Rs. 3,347.48 Million.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Profit After Tax for Q1 FY27 increased to Rs. 527.06 Million from Rs. 517.20 Million in Q1 FY26.
- Standalone Revenue from operations grew to Rs. 4,105.47 Million in Q1 FY27 from Rs. 3,347.48 Million in Q1 FY26.
⚠️ Concerns
- Standalone Basic and Diluted Earnings Per Share decreased to Rs. 5.20 in Q1 FY27 from Rs. 5.85 in Q4 FY26.
- Other income for Q1 FY27 decreased to Rs. 127.57 Million from Rs. 192.85 Million in Q1 FY26.
📅 Company Track Record
Rainbow Children's Medicare Ltd. approved FY26 results and recommended a ₹3.5 final dividend per equity share in May 2026. The current filing continues to report financial results and details business expansion plans.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Rainbow Children's Medicare's standalone net profit in Q1 FY27?
Rainbow Children's Medicare reported a standalone Profit After Tax of Rs. 527.06 Million for the quarter ended June 30, 2026.
What was the revenue from operations for Rainbow Children's Medicare in Q1 FY27?
The standalone revenue from operations for Rainbow Children's Medicare was Rs. 4,105.47 Million for the quarter ended June 30, 2026.
What executive appointment did Rainbow Children's Medicare make?
Mr. Anshuman Jaiswal was elevated to Chief Legal Officer and designated as a Senior Management Personnel with immediate effect.
What is the consideration for the acquisition of Super Prime Medical Care LLP by Rainbow Children's Medicare?
Rainbow Children's Medicare is acquiring 64% partnership interest in Super Prime Medical Care LLP for an aggregate consideration of Rs. 198 Million.
How many equity shares were allotted by Rainbow Children's Medicare under the Stock Unit Plan 2023?
The company allotted 7,483 equity shares of Rs. 10 each, consequent to the exercise of stock options by an eligible employee under the Rainbow Children's Medicare Limited - Employee Stock Unit Plan 2023.
Questions based on this BSE filing only. For information purposes.